← 治験一覧に戻る
食道扁平上皮癌患者における術後化学療法の効果予測
基本情報
- NCT ID
- NCT06490003
- ステータス
- 募集中
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 150
- 治験依頼者名
- City of Hope Medical Center
概要
Esophageal cancer remains a disease with a poor prognosis. Chemotherapy is an important part of its treatment, but there are cases in which chemotherapy is ineffective. The investigators aim to develop a model to predict the response to chemotherapy by DNA methylation of preoperative biopsy specimens to identify the chemotherapy ineffective group.
対象疾患
Esophageal Squamous Cell CarcinomaChemotherapy EffectDNA Methylation
介入
Fluoro Uracil(DRUG)
依頼者（Sponsor）
City Of Hope Medical Center(OTHER)
実施施設 (1)
国立大学法人山梨大学医学部附属病院
Chūō, Yamanashi, Japan(RECRUITING)